组蛋白去乙酰化酶抑制剂SAHA的合成研究-肿瘤资讯与疾病分类-中国癌症网 关键字： 组蛋白去乙酰化酶抑制剂;抗肿瘤药物;SAHA;合成 [gap=556]KEY WORDS] HDAC inhibitor; Anticancer drug; SAHA; Synthesis
基于66个网页-相关网页
polymeric anticancer drug 高分子抗癌物
anthracycline anticancer drug 蒽环类抗癌药物
Anticancer Drug Research and Development 抗肿瘤药物研究与开发
Anticancer Drug Clinical Study Sessions 抗肿瘤药物临床研究论坛
anticancer-drug 抗癌药物
new anticancer drug 抗癌新药
Oral anticancer drug 口服抗癌药物
plant anticancer drug 植物来源抗肿瘤药物
target anticancer drug 靶向抗癌药物
Multidrug resistance (MDR) means malignant cells are cross resistance to many other structurally and functionally unrelated anticancer drugs once they are resistant to a single anticancer drug.
多药耐药(multidrug resistance，MDR)是指肿瘤细胞接触一种抗癌药物后产生的对多种结构和功能迥异的抗癌药物的耐受性。
参考来源 - mdrSo the study of interaction between anticancer drug and DNA is helpful not only to understand the action mechanisms of some antitumor drugs. but also to the design of artificial DNA-targeting drug molecule.
因此，研究DNA和抗癌药物的相互作用不仅有助于了解抗癌药物的作用机理，而且对于人工合成DNA靶向抗癌药物分子的设计也很有意义。
参考来源 - 抗癌药物及其与DNA相互作用的电化学研究7-ethyl-10-hydroxycampthothecin (SN-38) is the intermediate which is used to synthesize Irinotecan(anticancer drug).
7-乙基-10-羟基喜树碱是一种喜树碱衍生物，是合成抗肿瘤药物伊立替康的中间体。
参考来源 - 7·2,447,543篇论文数据，部分数据来源于NoteExpress
SUTENT is an anticancer drug that you take by mouth.
索坦(舒尼替尼)是一种口服抗癌药物。
Oxaliplatin is a new anticancer drug that has good inhibitive effect on cancers.
奥沙利铂是一种新型的抗肿瘤药物，对多种癌种有效。
Oxaliplatin is a new anticancer drug that has good inhibitive effect on cancers.
摘要奥沙利铂是一种新型的抗肿瘤药物，对多种癌种有效。
应用推荐